tradit
vaccin
compos
live
attenu
kill
microorgan
altern
individu
protein
subunit
molecular
compon
microorgan
serv
antigen
trigger
antibodi
respons
immun
system
immun
system
coordin
molecular
cellular
respons
work
concert
check
spread
infect
past
decad
much
progress
dna
vaccin
dna
vaccin
includ
use
code
segment
viral
bacteri
genom
gener
immun
respons
howev
potenti
advantag
combin
rna
molecul
inorgan
nanoparticl
deliveri
consid
goal
achiev
immunosynergi
two
overcom
current
limit
dna
vaccin
tradit
vaccin
genet
medicin
hold
tremend
potenti
larg
literatur
alreadi
devot
topic
dna
vaccin
howev
consider
less
work
done
rnabas
vaccin
despit
sever
potenti
advantag
avoid
insert
replic
transcript
step
today
liter
thousand
paper
literatur
also
involv
rna
nanoparticl
howev
consid
whether
immunolog
profil
inorgan
nanoparticl
could
synerg
rna
potenti
immun
respons
summar
progress
date
rna
vaccin
address
molecular
correl
immunolog
respons
desir
potenti
rna
vaccin
nanoparticl
continu
progress
dna
vaccin
long
herald
recent
interest
rna
vaccin
emerg
rna
vaccin
evalu
varieti
diseas
summar
tabl
shown
tabl
diseas
rna
vaccin
test
includ
virus
avian
influenza
viru
cytomegaloviru
cmv
flaviviru
hepat
c
hiv
influenza
cancer
egmelanoma
measl
deliveri
rna
vaccin
accomplish
via
physic
mean
electropor
particl
base
method
gene
gun
lipid
nanoparticl
rout
rna
vaccin
administr
includ
subcutan
intraderm
intramuscular
except
one
case
rnai
use
overwhelm
major
rna
vaccin
construct
either
mrna
selfamplifi
rna
sarna
discuss
next
section
rna
vaccin
deliveri
translat
rna
sequenc
cytoplasm
circumv
mani
complic
dna
deliveri
nuclear
local
requir
integr
replic
transcript
step
necessari
structur
element
rna
vector
must
contain
order
directli
translat
protein
present
cytosol
illustr
figur
figur
illustr
basic
structur
featur
rna
vaccin
express
vector
exampl
mrna
construct
contain
cap
region
utr
code
sequenc
antigen
protein
tail
vaccin
antigen
express
encod
code
region
within
sequenc
promot
assembl
stabil
ribosom
mrna
gener
thought
mediat
mrna
decay
rate
selfamplifi
rna
sarna
repliconbas
vaccin
longer
rnabas
vaccin
typic
molecular
weight
approxim
kb
studi
sarna
vaccin
deriv
alphaviru
genom
alphavirus
consist
singl
copi
posit
singlestrand
rna
contain
genom
rna
encod
replic
machineri
sub
genom
rna
encod
viral
protein
caspid
glycoprotein
creat
vaccin
sub
genom
rna
encod
viral
structur
protein
replac
rna
encod
antigen
interest
first
replicas
complex
translat
cytoplasm
replicas
synthes
genom
antisens
rna
use
templat
genom
positivestrand
rna
synthesi
well
sub
genom
rna
encod
structur
antigen
viral
particl
produc
genet
sequenc
replac
encod
desir
antigen
celltocel
transmiss
sarna
vaccin
potenti
potent
mrna
vaccin
abil
replic
induc
stronger
broader
effect
humor
cellular
immun
respons
deliveri
advanc
packag
viruslik
particl
synthet
formul
ie
lipid
nanoparticl
nt
requir
cell
cultur
step
provid
simplic
safeti
benefit
use
viru
would
impos
receptor
recogn
pathogenassoci
molecular
pattern
pamp
one
type
dsrna
lot
recent
interest
polyinosin
polycytidyl
acid
poli
c
poli
c
pic
synthet
analog
viral
dsrna
one
strand
compos
entir
cytidin
strand
inosin
long
suggest
adjuv
potenti
vaccin
immunogen
activ
recent
consid
combin
chemotherapi
even
standalon
treatment
diseas
test
potenti
pic
treatment
summar
tabl
shown
tabl
varieti
cancer
infecti
diseas
treat
pic
case
pic
use
adjuv
conjunct
vaccin
combin
cytokin
howev
mani
case
pic
relat
compound
poli
iclc
polyinosinicpolycytidil
acidpolylysinecarboxymethylcellulos
use
activ
immunotherapeut
agent
similar
rna
vaccin
case
nake
pic
deliv
local
subcutan
intramuscular
inject
administ
via
intranas
intraperiton
intravascular
inject
mani
progress
beyond
mous
studi
human
one
key
factor
immunolog
activ
potenti
rna
nanoparticl
activ
innat
adapt
system
robust
molecular
respons
need
trigger
cell
immun
system
commun
perform
critic
function
tabl
present
overview
signal
system
tabl
immun
system
number
special
cell
includ
neutrophil
eosinophil
basophil
mast
cell
monocyt
dendrit
cell
macrophag
produc
cell
macrophag
dendrit
cell
signal
receiv
cell
express
variou
cytokin
major
cytokin
includ
limit
tumor
necrosi
factor
tnf
varieti
interleukin
elicit
differ
respons
varieti
specif
receiv
cell
even
organ
hypothalamu
respons
overt
robust
rang
acut
inflamm
recruit
varieti
cell
site
infect
releas
kill
agent
product
chemokin
chemoloc
chemoattract
agent
well
signal
varieti
molecul
involv
receiv
cell
cell
b
lymphocyt
natur
killer
nk
cell
neutrophil
cell
respons
receiv
cell
product
variou
class
antibodi
mhc
class
ii
cell
differenti
growth
signal
innat
immun
cell
provid
quick
gener
respons
typic
lead
inflamm
express
genet
encod
receptor
call
tolllik
receptor
tlr
recogn
gener
dangeror
microbeassoci
pattern
nonspecif
receptor
distinguish
strain
bacteria
virus
despit
lack
specif
innat
immun
cell
essenti
also
activ
adapt
immun
upon
recognit
microb
dendrit
cell
macrophag
consum
invad
becom
antigenpres
cell
activ
lymphocyt
essenti
cell
involv
innat
adapt
immun
produc
cytokin
especi
helper
h
lymphocyt
part
adapt
immun
consid
earli
respond
adapt
immun
activ
type
ii
interferon
also
consid
indic
adapt
immun
addit
antibodi
product
signal
molecul
get
upregul
adapt
immun
respons
includ
vcam
icam
cd
mhc
molecul
great
deal
work
alreadi
describ
immunolog
organ
nanoparticl
carbon
nanotub
liposom
etc
grow
bodi
literatur
suggest
inorgan
nanoparticl
also
immunolog
activ
highlight
figur
nanoparticl
compar
clearli
seen
type
nanoparticl
report
elicit
type
immunolog
respons
common
molecular
marker
investig
includ
variou
interleukin
chemokin
other
exampl
silicon
oxid
sio
titanium
dioxid
tio
fe
shown
activ
transcript
factor
nfkb
lead
increas
secret
cultur
brain
microglia
neuron
cell
human
vascular
endotheli
cell
human
keratinocyt
induct
report
mediat
via
potassium
channel
receptor
work
other
suggest
may
indic
nanoparticl
proinflammatori
activ
recent
consid
keyston
cytokin
diseas
therefor
result
interpret
caution
may
cell
type
rout
administr
depend
need
balanc
modul
cd
increas
serum
igg
igm
chemokin
mhci
mhcii
report
msn
nanoparticl
could
otherwis
contribut
desir
immunolog
compon
rna
vaccin
doubl
strand
rna
dsrna
discuss
next
nanovaccin
incorpor
rna
may
sever
advantag
first
core
nanoparticl
capabl
augment
immunogen
activ
shown
fig
recent
evid
seen
exampl
msn
cap
nanoparticl
test
conjunct
vaccin
shown
enhanc
sustain
tcell
respons
case
cap
protect
influenza
challeng
rna
molecul
encod
antigen
potenti
immun
respons
either
shown
previous
exampl
pic
signal
tolllik
receptor
tlr
pathogenassoci
molecular
pattern
pamp
immunostimulatori
thu
anoth
mean
achiev
synergi
shown
exampl
pic
contain
cap
nanoparticl
addit
molecular
signal
addit
advantag
cell
activ
induct
dendrit
cell
matur
lipid
coat
cap
coload
pic
sirna
ovalbumin
ova
antigen
refer
nanovaccin
shown
induc
effect
antitumor
immunolog
respons
therefor
similarli
anoth
attract
approach
achiev
synergi
cancer
coload
nanoparticl
pic
anoth
antitumor
agent
zoledron
acid
mention
previous
pic
much
need
doubl
edg
sword
cancer
capabl
stimul
immunogen
anticanc
approach
bob
langer
group
show
surfac
function
requir
iron
oxid
bind
rna
true
pic
consist
result
anoth
magnet
nanocarri
manganes
oxid
howev
great
deal
current
interest
target
combin
chemotherapi
pic
nanoparticl
especi
novel
approach
intratumor
immunotherapi
melanoma
potenti
cancer
addit
synergi
would
desir
abl
load
rna
onto
exampl
zinc
oxid
cobalt
oxid
nanoparticl
shown
possess
inher
anticanc
activ
schemat
synergist
advantag
approach
illustr
figur
figur
deliveri
pic
zinc
oxid
nanoparticl
would
expect
trigger
appropri
immun
respons
discuss
addit
activ
caus
transloc
interferon
regulatori
nuclear
factor
nf
across
nuclear
membran
nucleu
type
interferon
proinflammatori
cytokin
includ
would
expect
induc
would
essenti
activ
immun
system
tumor
signal
well
poli
ic
would
expect
trigger
apoptosi
essenti
caus
molecular
chemotherapeut
effect
mechan
apoptosi
caus
via
nanoparticl
ro
induct
etc
expect
poli
ic
thu
molecular
signal
pathway
may
complementari
lead
immunochemotherapeut
potenti
summari
rna
vaccin
develop
varieti
cancer
viral
infect
type
allergi
rna
vaccin
vector
thu
far
either
mrna
selfamplifi
rna
sarna
construct
doublestrand
rna
dsrna
pic
also
immunogen
addit
antivir
activ
evalu
immunotherapi
combin
immunochemotherapi
melanoma
sever
solid
tumor
well
ischemia
sever
acut
respiratori
syndrom
hepat
b
herp
zoster
children
cancer
other
liposom
deliveri
either
rna
vaccin
pic
evalu
immunogen
report
inorgan
nanoparticl
gone
surprisingli
underexploit
clearli
literatur
last
year
ampl
evid
report
particularli
calcium
phosphat
cap
mesopor
silic
nanoparticl
msn
also
iron
oxid
zinc
oxid
cobalt
oxid
pronounc
immunogen
activ
last
year
cap
msn
shown
profound
applic
nanovaccin
accordingli
rna
nanovaccin
may
therefor
promis
applic
cancer
case
explor
rna
nanobio
interfac
zinc
cobalt
iron
contain
nanoparticl
could
combin
indigen
anticanc
immunogen
activ
direct
rna
bind
may
therefor
achiev
synergi
long
sought
particularli
given
recent
report
antimetastat
activ
pic
imper
evalu
activ
conjunct
nanomateri
delong
curti
page
synergi
expect
zinc
oxid
nanoparticl
pic
